Nov 15, 2022 / 03:50PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
All right folks. Good afternoon, we're going to go ahead and get started. Welcome to the Jefferies 2022 London Healthcare Conference. I'm Brandon Couillard. I cover the life science tools and diagnostics space here at the firm. It is my great pleasure to have Exact Sciences with us back at the conference this year. And joining us this time, on behalf of the company, CEO, Kevin Conroy; as well as Megan Jones, Head of IR. I will turn it over to Kevin for some prepared remarks, and then we'll jump into Q&A. Kevin?
Kevin T. Conroy - Exact Sciences Corporation - Chairman of The Board & CEO
Thank you, Brandon. It's great to be back at this conference, and gosh, it's incredible, the turnout. Exact Sciences is totally focused on the eradication of cancer and making the earlier detection of cancer a routine part of medical care. Cancer, among people in this room, if you're under age 85, it's the #1 killer. And unfortunately, cancer is usually detected 70% of the time because you have symptoms,
Exact Sciences Corp at Jefferies London Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot